Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $433.75 | 28 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $242.72 | 17 | $0 (2024) |
| Mylan Specialty L.P. | $35.89 | 2 | $0 (2022) |
| Exact Sciences Corporation | $35.10 | 2 | $0 (2023) |
| Lilly USA, LLC | $21.70 | 1 | $0 (2022) |
| Novo Nordisk Inc | $19.46 | 1 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $18.87 | 1 | $0 (2022) |
| LINUS HEALTH, INC. | $17.46 | 1 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $15.40 | 1 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $14.31 | 1 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $12.84 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $58.13 | 3 | ABBVIE INC. ($58.13) |
| 2023 | $240.14 | 17 | ABBVIE INC. ($152.72) |
| 2022 | $135.48 | 8 | Mylan Specialty L.P. ($35.89) |
All Payment Transactions
28 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/24/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $23.49 | General |
| Category: NEUROSCIENCE | ||||||
| 05/17/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.17 | General |
| Category: NEUROSCIENCE | ||||||
| 05/11/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.47 | General |
| Category: NEUROSCIENCE | ||||||
| 10/24/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.81 | General |
| Category: NEUROSCIENCE | ||||||
| 10/19/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $33.98 | General |
| Category: NEUROSCIENCE | ||||||
| 10/11/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $19.46 | General |
| Category: Obesity | ||||||
| 10/03/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.10 | General |
| Category: NEUROSCIENCE | ||||||
| 09/25/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.43 | General |
| Category: NEUROSCIENCE | ||||||
| 09/21/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.88 | General |
| Category: NEUROSCIENCE | ||||||
| 09/14/2023 | LINUS HEALTH, INC. | CORE COGNITIVE EVALUATION (Device) | Food and Beverage | In-kind items and services | $17.46 | General |
| Category: DEVICE | ||||||
| 09/13/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $17.40 | General |
| Category: Oncology | ||||||
| 08/16/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.35 | General |
| Category: NEUROSCIENCE | ||||||
| 04/26/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.83 | General |
| Category: NEUROSCIENCE | ||||||
| 04/18/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.57 | General |
| Category: NEUROSCIENCE | ||||||
| 04/12/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $15.40 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/05/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $17.70 | General |
| Category: Oncology | ||||||
| 03/29/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.64 | General |
| Category: NEUROSCIENCE | ||||||
| 02/02/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.21 | General |
| Category: NEUROSCIENCE | ||||||
| 01/18/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $3.74 | General |
| Category: NEUROSCIENCE | ||||||
| 01/10/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.18 | General |
| Category: NEUROSCIENCE | ||||||
| 12/15/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $12.84 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/05/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.37 | General |
| Category: NEUROSCIENCE | ||||||
| 04/26/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.50 | General |
| Category: NEUROSCIENCE | ||||||
| 04/12/2022 | Mylan Specialty L.P. | Yupelri (Drug) | Food and Beverage | In-kind items and services | $17.32 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 03/17/2022 | Mylan Specialty L.P. | Yupelri (Drug) | Food and Beverage | In-kind items and services | $18.57 | General |
| Category: Anticholinergics, Inhaled | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 1,009 | 1,414 | $164,631 | $56,922 |
| 2022 | 11 | 466 | 537 | $61,655 | $26,266 |
All Medicare Procedures & Services
28 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 284 | 487 | $90,800 | $33,769 | 37.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 184 | 259 | $39,991 | $12,477 | 31.2% |
| G0446 | Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | Office | 2023 | 99 | 99 | $4,169 | $2,060 | 49.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 16 | 16 | $3,556 | $1,638 | 46.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 24 | 24 | $6,817 | $1,398 | 20.5% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 90 | 90 | $2,540 | $1,289 | 50.7% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 17 | 17 | $2,060 | $1,062 | 51.5% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 22 | 22 | $3,621 | $749.80 | 20.7% |
| 99091 | Collection and interpretation of physical parameters stored in computers and/or transmitted by the patient and/or caregiver to qualified health care professional, requiring 30 minutes or more, per 30 days | Office | 2023 | 18 | 21 | $2,205 | $735.63 | 33.4% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 44 | 62 | $2,046 | $590.24 | 28.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 50 | 52 | $2,487 | $346.05 | 13.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 32 | 42 | $2,009 | $344.76 | 17.2% |
| 81003 | Automated urinalysis test | Office | 2023 | 66 | 80 | $800.00 | $174.04 | 21.8% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 16 | 40 | $754.00 | $151.17 | 20.0% |
| 82044 | Urine microalbumin (protein) analysis | Office | 2023 | 11 | 11 | $440.00 | $67.21 | 15.3% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 17 | 63 | $170.10 | $38.70 | 22.8% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 19 | 29 | $166.75 | $31.71 | 19.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 153 | 200 | $34,902 | $16,031 | 45.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 96 | 105 | $15,765 | $5,846 | 37.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 13 | 13 | $2,889 | $1,354 | 46.9% |
| 99497 | Advance care planning, first 30 minutes | Office | 2022 | 13 | 13 | $1,560 | $885.68 | 56.8% |
| G0446 | Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | Office | 2022 | 40 | 40 | $1,684 | $825.42 | 49.0% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 38 | 38 | $1,072 | $530.59 | 49.5% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 29 | 31 | $1,023 | $295.66 | 28.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 19 | 28 | $1,339 | $252.36 | 18.8% |
About Hannah Wilker, NP-C
Hannah Wilker, NP-C is a Family healthcare provider based in Clayton, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/20/2021. The National Provider Identifier (NPI) number assigned to this provider is 1720748635.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Hannah Wilker, NP-C has received a total of $433.75 in payments from pharmaceutical and medical device companies, with $58.13 received in 2024. These payments were reported across 28 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($433.75).
As a Medicare-enrolled provider, Wilker has provided services to 1,475 Medicare beneficiaries, totaling 1,951 services with total Medicare billing of $83,188. Data is available for 2 years (2022–2023), covering 28 distinct procedure/service records.
Practice Information
- Specialty Family
- Location Clayton, GA
- Active Since 12/20/2021
- Last Updated 12/05/2023
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1720748635
Products in Payments
- VRAYLAR (Drug) $242.72
- JARDIANCE (Drug) $40.57
- Yupelri (Drug) $35.89
- Cologuard Collection Kit (Device) $35.10
- Wegovy (Drug) $19.46
- CORE COGNITIVE EVALUATION (Device) $17.46
- XARELTO (Drug) $15.40
- BREZTRI (Drug) $14.31
- ENTRESTO (Drug) $12.84
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Clayton
Mrs. Deborah Roberson, F.n.p, F.N.P
Family — Payments: $5,630
Amanda Smith
Family — Payments: $1,927
Mrs. Brittany Mccall, Fnp-C, FNP-C
Family — Payments: $1,710
Brittany Venable, Fnp, FNP
Family — Payments: $1,550
Miss. Guylante Jeune, Np, NP
Family — Payments: $1,191
Maghan Walker, Np, NP
Family — Payments: $1,036